These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 24078026)
1. Bayesian estimation of HIV-1 dynamics in vivo. Ushakova A; Pettersen FO; Mæland A; Lindqvist BH; Kvale D Math Med Biol; 2015 Mar; 32(1):38-55. PubMed ID: 24078026 [TBL] [Abstract][Full Text] [Related]
2. A Bayesian approach to parameter estimation in HIV dynamical models. Putter H; Heisterkamp SH; Lange JM; de Wolf F Stat Med; 2002 Aug; 21(15):2199-214. PubMed ID: 12210633 [TBL] [Abstract][Full Text] [Related]
3. Random changepoint modelling of HIV immunologic responses. Ghosh P; Vaida F Stat Med; 2007 Apr; 26(9):2074-87. PubMed ID: 16969894 [TBL] [Abstract][Full Text] [Related]
4. Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy. Torti C; Prosperi M; Motta D; Digiambenedetto S; Maggiolo F; Paraninfo G; Ripamonti D; Cologni G; Fabbiani M; Caputo SL; Sighinolfi L; Ladisa N; El-Hamad I; Quiros-Roldan E; Frank I Clin Microbiol Infect; 2012 May; 18(5):449-58. PubMed ID: 21919996 [TBL] [Abstract][Full Text] [Related]
5. Close association of CD8+/CD38 bright with HIV-1 replication and complex relationship with CD4+ T-cell count. Tuaillon E; Al Tabaa Y; Baillat V; Segondy M; Picot MC; Reynes J; Vendrell JP Cytometry B Clin Cytom; 2009 Jul; 76(4):249-60. PubMed ID: 19072838 [TBL] [Abstract][Full Text] [Related]
6. Inverse correlation between CD8+ lymphocyte apoptosis and CD4+ cell counts during potent antiretroviral therapy in HIV patients. Grelli S; d'Ettorre G; Lauria F; Montella F; Di Traglia L; Lichtner M; Vullo V; Favalli C; Vella S; Macchi B; Mastino A J Antimicrob Chemother; 2004 Mar; 53(3):494-500. PubMed ID: 14963063 [TBL] [Abstract][Full Text] [Related]
7. Estimation of population pharmacokinetic parameters of saquinavir in HIV patients with the MONOLIX software. Lavielle M; Mentré F J Pharmacokinet Pharmacodyn; 2007 Apr; 34(2):229-49. PubMed ID: 17211713 [TBL] [Abstract][Full Text] [Related]
8. Estimation and prediction with HIV-treatment interruption data. Adams BM; Banks HT; Davidian M; Rosenberg ES Bull Math Biol; 2007 Feb; 69(2):563-84. PubMed ID: 17211735 [TBL] [Abstract][Full Text] [Related]
9. Natural variation in HIV infection: Monte Carlo estimates that include CD8 effector cells. Heffernan JM; Wahl LM J Theor Biol; 2006 Nov; 243(2):191-204. PubMed ID: 16876200 [TBL] [Abstract][Full Text] [Related]
10. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. Kaufmann GR; Perrin L; Pantaleo G; Opravil M; Furrer H; Telenti A; Hirschel B; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Egger M; Battegay M; Arch Intern Med; 2003 Oct; 163(18):2187-95. PubMed ID: 14557216 [TBL] [Abstract][Full Text] [Related]
11. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression. Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945 [TBL] [Abstract][Full Text] [Related]
12. Joint modeling of longitudinal data and informative dropout time in the presence of multiple changepoints. Ghosh P; Ghosh K; Tiwari RC Stat Med; 2011 Mar; 30(6):611-26. PubMed ID: 21337357 [TBL] [Abstract][Full Text] [Related]
13. Modeling HIV-1 dynamics and fitness in cell culture across scales. Immonen T; Somersalo E; Calvetti D Bull Math Biol; 2014 Feb; 76(2):486-514. PubMed ID: 24510727 [TBL] [Abstract][Full Text] [Related]
14. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients]. Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327 [TBL] [Abstract][Full Text] [Related]
15. Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy. Stone SF; Price P; French MA HIV Med; 2005 Jul; 6(4):278-83. PubMed ID: 16011533 [TBL] [Abstract][Full Text] [Related]
16. Changes in T-cell subpopulations during four years of suppression of HIV-1 replication in patients with advanced disease. Lepej SZ; Begovac J; Vince A FEMS Immunol Med Microbiol; 2006 Apr; 46(3):351-9. PubMed ID: 16553807 [TBL] [Abstract][Full Text] [Related]
17. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy. Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217 [TBL] [Abstract][Full Text] [Related]
18. Markov modelling of changes in HIV-specific cytotoxic T-lymphocyte responses with time in untreated HIV-1 infected patients. Kousignian I; Autran B; Chouquet C; Calvez V; Gomard E; Katlama C; Rivière Y; Costagliola D; Stat Med; 2003 May; 22(10):1675-90. PubMed ID: 12720304 [TBL] [Abstract][Full Text] [Related]
19. Relationship between CD38 expression on peripheral blood T-cells and monocytes, and response to antiretroviral therapy: a one-year longitudinal study of a cohort of chronically infected ART-naive HIV-1+ patients. Almeida M; Cordero M; Almeida J; Orfao A Cytometry B Clin Cytom; 2007 Jan; 72(1):22-33. PubMed ID: 17051525 [TBL] [Abstract][Full Text] [Related]
20. CD38 expression on CD8 T cells has a weak association with CD4 T-cell recovery and is a poor marker of viral replication in HIV-1-infected patients on antiretroviral therapy. Steel A; John L; Shamji MH; Henderson DC; Gotch FM; Gazzard BG; Kelleher P HIV Med; 2008 Feb; 9(2):118-25. PubMed ID: 18257774 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]